Latest Earnings Results: Q2 '26
Estimated EPS
-$0.18
Reported EPS
-$0.18
Surprise
---
Estimated Rev
$27.01M
Reported Rev
$27.21M
Surprise
+0.75%
• Reported GAAP EPS of -$0.22 down -46.67% YoY • Mdxhealth maintains its 2026 revenue guidance of $110-115 million, representing 20-26% growth over 2025 excluding Resolve, and expects a return to positive adjusted EBITDA as Mdxhealth exits the year 2026.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.09 | -- | -- | N/A |
Q2 '26 | -$0.18 | -$0.18 | -- | EXPECTED |
Q1 '26 | -$0.14 | -$0.19 | -31.35% | MISSED |
Q4 '25 | -$0.13 | -$0.17 | -35.48% | MISSED |
Q3 '25 | -$0.11 | -$0.16 | -49.73% | MISSED |